, APAC
Photo by Markus Spiske from Unsplash

AXA XL appoints new head of mid-market for APAC & Europe

She has been with AXA since 2012.

AXA XL has appointed Laëtitia Lebas as the head of Mid-Market for APAC & Europe. 

In her new role, Lebas will spearhead the implementation of AXA XL's mid-market strategy across Europe, Asia, and Australia, working closely with regional teams, local leadership, and AXA's General Insurance entities.

Julien Guénot, Regional Manager for Southern Europe at AXA XL and Executive Sponsor for the APAC & Europe Mid-Market initiative, emphasised the opportunity to extend AXA XL's expertise from large corporates to larger mid-market clients in collaboration with other AXA entities.

ALSO READ: Aijiao Ruan becomes senior underwriter at AXA XL Insurance Asia

Laëtitia Lebas's career with AXA began in 2012 at AXA France as a Global Account Manager for AXA Santé Collective. 

Over the years, she assumed various roles, including International Sales Director for AXA Creditor, Regional Director for Western Europe, and Legal Representative for Genworth entities in France. 

In 2017, she joined the Executive Committee of AXA Partners France and took on the role of Sales Director for Credit Lifestyle Protection and Motor & Banking Assistance.

 

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.